Drug Shortage Report for TEVA-DICLOFENAC EC
Report ID | 99453 |
Drug Identification Number | 00808539 |
Brand name | TEVA-DICLOFENAC EC |
Common or Proper name | DICLOFENAC 25MG TABLETS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | DICLOFENAC SODIUM |
Strength(s) | 25MG |
Dosage form(s) | TABLET (ENTERIC-COATED) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | M01AB |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-08-01 |
Actual start date | |
Estimated end date | |
Actual end date | 2020-06-29 |
Shortage status | Avoided shortage |
Updated date | 2020-07-10 |
Company comments | Will be allocating to cover our market until resupply in Aug 2020 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2020-07-10 | French | Compare |
v10 | 2020-07-10 | English | Compare |
v9 | 2019-12-05 | French | Compare |
v8 | 2019-12-05 | English | Compare |
v7 | 2019-12-05 | French | Compare |
v6 | 2019-12-05 | English | Compare |
v5 | 2019-11-28 | French | Compare |
v4 | 2019-11-28 | English | Compare |
v3 | 2019-11-22 | English | Compare |
v2 | 2019-11-21 | French | Compare |
v1 | 2019-11-21 | English | Compare |
Showing 1 to 11 of 11